Acorda to buy Civitas By: MarketMinute.com Stock News September 24, 2014 at 12:02 PM EDT Acorda Therapeutics Inc. (Nasdaq: ACOR) will pay approximately $525 million in cash to acquire Civitas Therapeutics. Shares of the biopharmaceutical leaped $5.64 to $34.99. Related Stocks: Acorda Therapeutics